Precision medicine and drug development based on maximising screening of limited human cancerous tissue in 3D with microfluidic technology.

ScreenIn3D

ScreenIn3D is getting ready to attend the Next Gen Organ-on-Chip & Organoids workshop organized by CSEM in Zurich on August 24-25th!

A fantastic venue to meet #clinicians, #scientists, #researchers and decision makers from the #pharma & #biotech industry and share the latest breakthroughs in #OrganOnChip.
 
We are delighted to contribute to the exciting scientific program with a talk from our CEO, Michele Zagnoni, who will be showcasing our tumour-on-a-chip platform for precision oncology. We hope to see you there at 4:50pm on day 1.
 
#OrganOnChip #Organoids #CSEM #Research #TumourOnAChip

Screenin3D is a company that develops microfluidic technology for cancer therapy assessment, enabling the testing of CAR-T cells and combination therapy on miniaturized solid cancer models.

COM:SCREENIN3D

Screenin3D

Filings Not Available